Discover our impact all over the world.

Numbers displayed on the map are a representation of the activity in each country. Once you use the filter selections below, you will have the opportunity to explore projects and faculty in each country.

Projects + Faculty = Activity Number

##

Overview

Projects 285
Countries 141
Faculty 360
Health Topics 122

Filter from the selections below

Clear All Filters
Back to search

Impower-022 Phase III safety and efficacy trial of once monthly Islatravir for HIV prevention among cisgender women

This is a large randomized, active-controlled clinical trial to determine safety and efficacy of a novel antiretroviral agent to prevent HIV infection in cisgender women. The trial is sponsored by Merck with leadership from Merck, ICRC and the Bill and Melinda Gates Foundation.

Countries 
Active Dates 
01/01/2021 to 12/31/2025
Faculty Involved 
Organizations 
Health Topics